47045-TJK-T-HOPE-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Assistance to Tajikistan in the Tuberculosis burden decrease - Tajikistan (01-Jan-2016-31-Mar-2018)</narrative> Tajikistan, Tuberculosis, Project HOPE - the People to People Health Foundation Goal: To decrease the burden of tuberculosis in Tajikistan by ensuring universal access to timely and quality diagnosis and treatment of all forms of TB. Objectives: To enhance the response to TB epidemic by strengthening involvement of communities, advocacy, communication and social mobilization; To ensure universal access to early and quality diagnosis of all forms of TB including M/XDR-TB; To ensure universal access to quality patient-centered treatment of all forms of TB including M/XDR-TB with appropriate patient support; To provide appropriate TB care for high-risk population groups: prisoners and TB/HIV co-infection; To strengthen the National TB Program management and improve the health system’s performance for effective TB control. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation Project HOPE - the People to People Health Foundation The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Olga Avdeeva Fund Portfolio Manager +41 58 791 1700 olga.avdeeva@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Tajikistan Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 10505287.00 Global Fund commitment to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 394231.00 Global Fund disbursement to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 803562.62 Global Fund disbursement to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 669077.16 Global Fund disbursement to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 226575.16 Global Fund disbursement to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 595861.39 Global Fund disbursement to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 1397768.22 Global Fund disbursement to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 6484.00 Funds returned to the Global Fund from TJK-T-HOPEP01. Project HOPE - the People to People Health Foundation The Global Fund to Fight AIDS, Tuberculosis and Malaria -6484.00 Global Fund commitment to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 1299666.00 Global Fund disbursement to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 1371933.35 Global Fund disbursement to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 2823764.00 Global Fund disbursement to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 20000.00 Global Fund disbursement to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 20000.00 Global Fund commitment to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation -922848.10 Global Fund commitment to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 1224229.00 Global Fund commitment to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 1224229.00 Global Fund disbursement to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 217851.90 Funds returned to the Global Fund from TJK-T-HOPEP01. Project HOPE - the People to People Health Foundation The Global Fund to Fight AIDS, Tuberculosis and Malaria -217851.90 Global Fund commitment to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 41227.59 Funds returned to the Global Fund from TJK-T-HOPEP01. Project HOPE - the People to People Health Foundation The Global Fund to Fight AIDS, Tuberculosis and Malaria -41227.59 Global Fund commitment to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation 8323.64 Funds returned to the Global Fund from TJK-T-HOPEP01. Project HOPE - the People to People Health Foundation The Global Fund to Fight AIDS, Tuberculosis and Malaria -8323.64 Global Fund commitment to TJK-T-HOPEP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Project HOPE - the People to People Health Foundation <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>MDR TB-other 1: Coverage of second-line TB treatment: percentage of detected MDR-TB cases, which began treatment according to national guidelines that are in line with WHO recommendations</narrative> Module: MDR-TB. <narrative>MDR TB-other 1: Coverage of second-line TB treatment: percentage of detected MDR-TB cases, which began treatment according to national guidelines that are in line with WHO recommendations</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 625; Denominator: 872. Numerator: 437; Denominator: 458. Numerator: 437; Denominator: 458. Numerator: 346; Denominator: 346. Numerator: 511; Denominator: 540. Numerator: 384; Denominator: 416. Numerator: 763; Denominator: 801. Numerator: 437; Denominator: 583. <narrative>MDR TB-other 1: Number of pre-XDR and XDR-TB patients enrolled in treatment</narrative> Module: MDR-TB. <narrative>MDR TB-other 1: Number of pre-XDR and XDR-TB patients enrolled in treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 625. Numerator: 0; Denominator: 0; Percentage: 0%. Numerator: 0; Denominator: 0; Percentage: 0%. Numerator: 0; Denominator: 0; Percentage: 0%. Numerator: 0; Denominator: 0; Percentage: 0%. Numerator: 437. Numerator: 437. Numerator: 346. Numerator: 511. Numerator: 384. Numerator: 763. Numerator: 437. Numerator: 432; Denominator: 590; Percentage: 73.2%. Numerator: 5; Denominator: 437; Percentage: 1.1%. Numerator: 181; Denominator: 437; Percentage: 41.4%. Numerator: 256; Denominator: 437; Percentage: 58.6%. <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative> Module: MDR-TB. <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 31; Denominator: 536. Numerator: 23; Denominator: 437. Numerator: 23; Denominator: 437. Numerator: 25; Denominator: 399. Numerator: 26; Denominator: 511. Numerator: 19; Denominator: 300. Numerator: 38; Denominator: 763. Numerator: 27; Denominator: 529. <narrative>DOTS-other 2: Number of TB patients, all forms, who receive incentives for treatment adherence</narrative> Module: TB care and prevention. <narrative>DOTS-other 2: Number of TB patients, all forms, who receive incentives for treatment adherence</narrative> Geographic coverage: National. Aggregation: Cumulative annually.